New strategies for managing anemia of chronic kidney disease.
Schmid H, Schiffl H, Lederer SR.
Cardiovasc Hematol Agents Med Chem · review; journal article · DOI 10.2174/187152512803530342 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för peginesatide. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
14 hitsPeginesatide (Omontys) for anemia in chronic kidney failure.
Författaruppgift saknas
Med Lett Drugs Ther · journal articlePeginesatide for the treatment of anemia in the nephrology setting.
Graul AI.
Drugs Today (Barc) · journal article · DOI 10.1358/dot.2012.48.6.1825620Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis.
Mikhail A.
J Blood Med · review-article; journal article · DOI 10.2147/jbm.s23270Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing.
Möller I, Thomas A, Geyer H, Schänzer W, Thevis M.
Anal Bioanal Chem · research support, non-u.s. gov't; validation study; journal article · DOI 10.1007/s00216-012-6043-2Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events.
Green JM, Leu K, Worth A, Mortensen RB, Martinez DK, Schatz PJ, Wojchowski DM, Young PR.
Exp Hematol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.exphem.2012.02.007Absorption, distribution, metabolism and excretion of peginesatide, a novel erythropoiesis-stimulating agent, in rats.
Woodburn KW, Holmes CP, Wilson SD, Fong KL, Press RJ, Moriya Y, Tagawa Y.
Xenobiotica · research-article; journal article · DOI 10.3109/00498254.2011.649310New anemia therapies: translating novel strategies from bench to bedside.
Macdougall IC.
Am J Kidney Dis · review; journal article · DOI 10.1053/j.ajkd.2011.11.013Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients.
Macdougall IC, Wiecek A, Tucker B, Yaqoob M, Mikhail A, Nowicki M, MacPhee I, Mysliwiec M, Smolenski O, Sułowicz W, Mayo M, Francisco C, Polu KR, Schatz PJ, Duliege AM.
Clin J Am Soc Nephrol · clinical trial, phase ii; comparative study; research support, non-u.s. gov't; research-article; multicenter study; journal article · DOI 10.2215/cjn.10831210Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
Leuenberger N, Saugy J, Mortensen RB, Schatz PJ, Giraud S, Saugy M.
Forensic Sci Int · journal article · DOI 10.1016/j.forsciint.2011.07.012Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes.
Möller I, Thomas A, Geyer H, Schänzer W, Thevis M.
Rapid Commun Mass Spectrom · research support, non-u.s. gov't; journal article · DOI 10.1002/rcm.5109Genotoxic assessment and toxicity evaluation of peginesatide in CByB6F1 hybrid mice.
Woodburn KW, Schatz PJ, Wilson S, Fong KL, Wagner VO, Gudi R, Krsmanovic L, Paranjpe M, Shah SA.
Drug Chem Toxicol · journal article · DOI 10.3109/01480545.2010.510140Peginesatide: a potential erythropoiesis stimulating agent for the treatment of anemia of chronic renal failure.
Doss S, Schiller B.
Nephrol Nurs J · research support, non-u.s. gov't; journal articleChronic kidney disease-associated anemia: new remedies.
Del Vecchio L, Cavalli A, Tucci B, Locatelli F.
Curr Opin Investig Drugs · review; journal article